Liver metastases are one of the most common sites of cancer spread, and the survival rates are very low. However, Cancer Center at Illinois (CCIL) researchers recently identified a new promising ...

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated ...

It’s hard to be prepared to react to the news of a cancer diagnosis, but this list of questions will help you get your ...

Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer ...

Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...

The therapeutic landscape of metastatic castration-resistant prostate cancer (mCRPC) has evolved substantially over the past decade, with androgen receptor pathway inhibitors, taxanes, poly ...

Common encouragements can inadvertently erase the incurable biology of metastatic breast cancer and shift conversations away from prognosis, uncertainty, and ongoing treatment burden. Avoidance of ...

New analysis revealed cervical cancer lung metastases incidence and identified advanced stage and tumour type as key risk factors. Read more.

Metastatic disease—when cancer spreads from the primary tumor to other parts of the body—is the cause of most cancer deaths. While researchers understand how cancer cells escape the primary site to ...

For this week’s Managed Care Cast episode, The American Journal of ManagedCare ® (AJMC ®) spoke with Anuraag R. Kansal, PhD, ...

Gilead secures EC approval to expand Trodelvy into first-line metastatic TNBC, marking a new treatment option and broadening ...